Abstract
Get full access to this article
View all access options for this article.
References
1.
Watson
KE
Tsuyuki
RT.
Pharmacists must combat mis/disinformation . Can Pharm J (Ott) 2021 ;154 (2 ):68-9.
2.Updated: WHO now doesn’t recommend avoiding ibuprofen for COVID-19 symptoms . March 17 , 2020 . Available: https://www.sciencealert.com/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-symptoms (accessed May 4, 2021 ).
3.
Fang
L
Karakiulakis
G
Roth
M
. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection ? Lancet Respir Med 2020 ;8 (4 ):e21 .
4.
Qiao
W
Wang
C
Chen
B
, et al . Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats . Cardiology 2015 ;131 (2 ):97 -106 .
5.
Fang
L
Karakiulakis
G
Roth
M.
Correction to Lancet Respir Med 2020;8:e21 . Lancet Respir Med 2020 ;8 (6 ):e54 .
6.EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19 . March 18 , 2020 . Available: https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19 (accessed May 4, 2021 ).
7.AMK (Drug Commission of German Pharmacists) . BMG: Belieferung bzw. Abgabe von Paracetamol-haltigen Arzneimitteln durch Hersteller, pharmazeutische Großhändler und Apotheken [Federal Ministry of Health: Delivery or dispensing of paracetamol-containing drugs by manufacturers, pharmaceutical wholesalers and pharmacies] . Available: https://www.abda.de/fuer-apotheker/arzneimittelkommission/amk-nachrichten/detail/14-20-informationen-der-institutionen-und-behoerden-bmg-mengenbeschraenkte-belieferung-bzw-abgabe-von-paracetamol-haltigen-arzneimitteln-durch-hersteller-pharmazeutische-grosshaendler-und-apotheken/ (accessed May 4, 2021 ).